FGFR2 and colorectal cancer: Compared to colorectal cancer, GECs express a higher genomic heterogeneity with each patient demonstrating unique molecular patterns; as a result, ctDNA profiling may provide a more accurate representation of a GEC genomic profile.33 The FIGHT study11 evaluated FGFR2 overexpression by IHC and ctDNA.